Heart Valve Devices – Market Insights – Europe

The European heart valve device market will continue to experience moderate growth, largely driven by the new product launches and the rapid adoption of THV devices. Positive clinical outcomes supporting THV devices and the emergence of novel products expanding the existing patient population will drive continued growth in the European heart valve device market.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for heart valve devices in Europe from 2019 through 2033.

The competitive landscape for the THV device market is evolving.

Which competitors have the most diverse portfolios in the heart valve device space?

How are companies gaining competitive edge through mergers and acquisitions?

New THV technologies, including TTVR and TMVI, are emerging in the European market.

How will the recent approval of TTVR and TMVI devices impact the European heart valve devices market?

Which new THV devices are going to enter the market? What will be the impact of the THV devices recently approved in market?

Will new TMVR devices be able to compete with MitraClip when they enter the market?

How will the TTVR market grow over the forecast period?

The THV replacement device segment represents rapid growth opportunity in the European heart valve device market.

How are clinical studies and guidelines impacting the uptake of THV replacement devices?

What clinical trials are currently underway that could further expand the addressable patient population for TAVI?

What will be the market impact of the approval of expanded indications for TAVI?

How will the preliminary results from the ongoing clinical trials impact the adoption of heart valve devices?

How will the change in reimbursements impact the TAVI market?

Market leaders in the European heart valve device market are consolidating or capturing sales and improving market shares by acquiring smaller competitors.

What will be the impact of the recent merger and acquisition activities on the heart valve device market?

What technologies are larger players adding to their product portfolios through acquisitions?